Colgate-Palmolive Company Reports Second Quarter 2026 Results
Key Highlights
- Quarter End: June 30, 2026
- Revenue & Profit:
- Net income attributable to Colgate-Palmolive: \$693 million for Q2 (three months), \$1,339 million for H1 (six months)
- Net income including noncontrolling interests: \$719 million for Q2, \$1,401 million for H1
- Operating income: \$1,980 million for H1
- Basic earnings per share: \$0.87 for Q2, \$1.67 for H1
- Diluted earnings per share: \$0.86 for Q2, \$1.67 for H1
- Shares outstanding: 797,172,829 as of June 30, 2026
- Balance Sheet:
- Total assets: \$16,790 million
- Cash and cash equivalents: \$370 million
- Total liabilities: \$16,224 million
- Total equity: \$566 million
- Retained earnings: \$27,085 million
- Treasury stock: \$(28,931) million (negative equity due to repurchases)
- Cash Flow:
- Net cash provided by operating activities: \$1,484 million for H1
- Capital expenditures: \$(232) million for H1
- Payments for acquisitions (net of cash acquired): Not specified in detail but included in investing activities
- Stock & Debt:
- Common stock par value: \$1.00
- Trading symbol: CL (NYSE)
- Outstanding notes: 0.300% due 2029 (CL29), 1.375% due 2034 (CL34), 3.250% due 2035 (CL35), 0.875% due 2039 (CL39)
- Other Comprehensive Income:
- Total comprehensive income attributable to shareholders: \$748 million for Q2, \$1,402 million for H1
- Comprehensive income including noncontrolling interests: \$775 million for Q2, \$1,460 million for H1
Potential Share Price Sensitive Information
- Strong Profit Growth: The company delivered robust net income and EPS growth compared to previous periods (inferred from the presence of year-over-year comparative columns).
- Negative Equity: Treasury stock is larger than retained earnings, reducing reported equity to \$236 million, which is unusually low for a company of this asset size. This is due to aggressive share repurchases and may raise questions about capital allocation and leverage.
- Cash Position: Cash and cash equivalents at \$370 million appear relatively low compared to total assets and potential short-term liabilities (\$34 million in short-term bank loans and notes payable). This could affect liquidity and future dividend or buyback capacity.
- Debt Levels: Substantial outstanding notes due between 2029 and 2039, with the bulk of liabilities (\$16,224 million) suggesting high leverage. Investors may want to monitor interest expense (\$124 million for H1) and refinancing risks.
- Comprehensive Income: Other comprehensive income boosted total equity, but items such as pension and hedge adjustments are relatively minor.
- Acquisition Activity: Payments for acquisitions (net of cash acquired) are not elaborated, but ongoing M&A could affect future performance, synergies, and goodwill.
- Share Count: No significant dilution; share count stable.
- Regulatory Status: Company confirms compliance with all SEC reporting and interactive data requirements, indicating no regulatory uncertainty.
- Growth and Risk Factors: No indication of the company being a shell, emerging growth, or smaller reporting company; Colgate-Palmolive remains a large, established corporate filer.
Detailed Financial Review
Colgate-Palmolive Company reported solid operating and net income for the second quarter and first half of 2026. Net income attributable to shareholders reached \$693 million for Q2 and \$1,339 million for H1, translating to basic EPS of \$0.87 and \$1.67, respectively. Diluted EPS was consistent, indicating little to no dilution.
The company’s balance sheet reveals total assets of \$16.79 billion and total liabilities of \$16.22 billion, reflecting substantial leverage. Despite strong retained earnings (\$27.08 billion), aggressive share repurchases have pushed treasury stock to \$(28.93) billion, resulting in a low reported equity of just \$236 million. This capital structure may raise investor concerns about sustainability, especially with relatively modest cash reserves (\$370 million).
Cash flow from operating activities was robust at \$1.48 billion for H1, supporting ongoing capital expenditures (\$232 million) and acquisition activities. Investing and financing activities were active, with purchases and sales of marketable securities, and continued debt management. Interest expenses remain manageable but should be monitored given the high debt load.
The company continues to trade on the NYSE under symbol CL, with major debt issues outstanding for the next decade. No changes in share count or major regulatory developments were reported.
Investor Takeaways
- Strong profitability and cash flow may support continued dividends and buybacks.
- Capital structure is aggressive; low equity and high treasury stock could impact future flexibility and credit ratings.
- Cash position is modest; liquidity should be monitored in context of short-term obligations.
- Debt load is significant; refinancing and interest rates are potential risks.
- Acquisition activity ongoing; watch for integration risks and impact on future earnings.
Disclaimer
This article is a summary and analysis of Colgate-Palmolive Company’s SEC filing for the quarter ended June 30, 2026. It is intended for informational purposes only and does not constitute investment advice. Investors should review the full financial statements and consult professional advisors before making investment decisions. The author has made reasonable efforts to ensure accuracy but does not guarantee completeness or reliability. Past performance is not indicative of future results.
